Table 3 Subgroup analysis infants of GDM study population with or without neonatal hypoglycemia
Study cohort GDM No Hypoglycemia n = 18 | Study cohort GDM ≥1 Hypoglycemia n = 17 | p | ||
|---|---|---|---|---|
Maternal characteristics | ||||
Pre-pregnancy BMI (kg/m2) | Median (Q1, Q3) | 26.0 (24.3–27.2) | 29.4 (24.1–34.0) | 0.10 |
Gestational weight gain categoriesa | n (%) | 0.47 | ||
Insufficient | 4 (22%) | 6 (35%) | ||
Adequate | 6 (33%) | 2 (12%) | ||
Excessive | 8 (44%) | 9 (53%) | ||
Maternal insulin therapy | n (%) | 7 (39%) | 7 (41%) | 1.0 |
Infant characteristics | ||||
Female | n (%) | 12 (67%) | 6 (35%) | 0.09 |
Birth weight (g) | Median (Q1, Q3) | 3555 (2998–3878) | 3530 (3340–3750) | 0.93 |
SDS birth weight | Median (Q1, Q3) | 0.28 (−0.33–0.90) | 0.38 (−0.31–0.83) | 1.0 |
Blood glucose postnatal (mg/dl) | Median (Q1, Q3) | |||
0-1 h | 67 (58–87) | 49 (37–67) | 0.02 | |
1-3 h | 65 (58–68) | 48 (40–63) | 0.05 | |
3-6 h | 65 (58–70) | 64 (51–70) | 0.60 | |
6-12 h | 60 (58–67) | 49 (43–66) | 0.04 | |
12-24 h | 69 (60–74) | 55 (52–63) | 0.04 | |
Minimal blood glucose level | Median (Q1, Q3) | 55 (52–59) | 36 (32–40) | < 0.0001 |
Infants’ body composition | ||||
Fat mass (g) | Median (Q1, Q3) | 377 (280–582) | 380 (350–444) | 0.73 |
Fat mass / total body mass (%) | Median (Q1, Q3) | 12.5 (9.3–16.0) | 11.3 (10.1–13.8) | 0.44 |
Fat-free mass (g) | Median (Q1, Q3) | 2891 (2535–3127) | 2996 (2678–3251) | 0.46 |